Strategic Partnerships CSAB Members? Abbvie Neuroscience & Neurology $12.3 Million NIDA Grant Reviewed > 4,000 Opportunities ARCH Venture Partners Scientists & Technology Developers Top-tier Investors The Rockefeller University 2014 Top- quartile Ranked Venture Capital San Diego Office $3.375 Billion Exit Gates Foundation 1.02 DPI Leroy Hood, M.D., Ph.D. Lydian Neurosciences Scientific Expertise Sundar Kodiyalam Substantial Exit History Divestitures $1 Billion Genentech Collaboration Infectious Disease, Oncology, Microbiome The Rockefeller University high-quality, cutting edge life science companies WuXi PharmaTech Weill Cornell Medicine Harvard Medical School Non- Dilutive Funding Exceptional Track Record Entrepreneurs Tachi Yamada, M.D. Corporate Spinouts Oncology Diversity Jan Lundberg, Ph.D. Lodo Therapeutics CPRIT Pfizer Ventures MD Anderson Cancer Center Eli Lilly Advisory & Corporate Boards Proniras WRF Capital Weill Cornell Medicine Petra Pharma Gates Foundation 150+ Years’ Experience Syndication Rodeo Therapeutics Academic & Research Institutions Syndication Partners Seattle Office Targeted Therapeutic (Asset) Financing Temasek Fund I net IRR of 58.4% Operating Partners? Magnolia Neurosciences Gene Yeo, Ph.D. Turn- Key Facilities Lewis Cantley Rodeo Therapeutics University of Minnesota Singapore Office Bruce L.A. Carter, Ph.D. Uniformed Services University 2.85 DVPI UT Southwestern Medical Center Case Western Reserve Employees Steve Gillis, Ph.D. (BARDA) – on updated slide deck Columbia University Dana Farber Cancer Capital- efficiency Alexandria Venture Investments AI & Machine Learning Apogen Biotechnologies UT Southwestern 58.43% IRR New York Office Lodo Therapeutics Penn State Strategic Partnerships CSAB Members? Abbvie Neuroscience & Neurology $12.3 Million NIDA Grant Reviewed > 4,000 Opportunities ARCH Venture Partners Scientists & Technology Developers Top-tier Investors The Rockefeller University 2014 Top- quartile Ranked Venture Capital San Diego Office $3.375 Billion Exit Gates Foundation 1.02 DPI Leroy Hood, M.D., Ph.D. Lydian Neurosciences Scientific Expertise Sundar Kodiyalam Substantial Exit History Divestitures $1 Billion Genentech Collaboration Infectious Disease, Oncology, Microbiome The Rockefeller University high-quality, cutting edge life science companies WuXi PharmaTech Weill Cornell Medicine Harvard Medical School Non- Dilutive Funding Exceptional Track Record Entrepreneurs Tachi Yamada, M.D. Corporate Spinouts Oncology Diversity Jan Lundberg, Ph.D. Lodo Therapeutics CPRIT Pfizer Ventures MD Anderson Cancer Center Eli Lilly Advisory & Corporate Boards Proniras WRF Capital Weill Cornell Medicine Petra Pharma Gates Foundation 150+ Years’ Experience Syndication Rodeo Therapeutics Academic & Research Institutions Syndication Partners Seattle Office Targeted Therapeutic (Asset) Financing Temasek Fund I net IRR of 58.4% Operating Partners? Magnolia Neurosciences Gene Yeo, Ph.D. Turn- Key Facilities Lewis Cantley Rodeo Therapeutics University of Minnesota Singapore Office Bruce L.A. Carter, Ph.D. Uniformed Services University 2.85 DVPI UT Southwestern Medical Center Case Western Reserve Employees Steve Gillis, Ph.D. (BARDA) – on updated slide deck Columbia University Dana Farber Cancer Capital- efficiency Alexandria Venture Investments AI & Machine Learning Apogen Biotechnologies UT Southwestern 58.43% IRR New York Office Lodo Therapeutics Penn State
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Strategic Partnerships
CSAB Members?
Abbvie
Neuroscience & Neurology
$12.3 Million NIDA Grant
Reviewed > 4,000 Opportunities
ARCH Venture Partners
Scientists & Technology Developers
Top-tier Investors
The Rockefeller University
2014 Top-quartile Ranked
Venture Capital
San Diego Office
$3.375 Billion Exit
Gates Foundation
1.02 DPI
Leroy Hood, M.D., Ph.D.
Lydian Neurosciences
Scientific Expertise
Sundar Kodiyalam
Substantial Exit History
Divestitures
$1 Billion Genentech Collaboration
Infectious Disease, Oncology, Microbiome
The Rockefeller University
high-quality, cutting edge life science companies
WuXi PharmaTech
Weill Cornell Medicine
Harvard Medical School
Non-Dilutive Funding
Exceptional Track Record
Entrepreneurs
Tachi Yamada, M.D.
Corporate Spinouts
Oncology
Diversity
Jan Lundberg, Ph.D.
Lodo Therapeutics
CPRIT
Pfizer Ventures
MD Anderson Cancer Center
Eli Lilly
Advisory & Corporate Boards
Proniras
WRF Capital
Weill Cornell Medicine
Petra Pharma
Gates Foundation
150+ Years’ Experience
Syndication
Rodeo Therapeutics
Academic & Research Institutions
Syndication Partners
Seattle Office
Targeted Therapeutic (Asset) Financing
Temasek
Fund I net IRR of 58.4%
Operating Partners?
Magnolia Neurosciences
Gene Yeo, Ph.D.
Turn-Key Facilities
Lewis Cantley
Rodeo Therapeutics
University of Minnesota
Singapore Office
Bruce L.A. Carter, Ph.D.
Uniformed Services University
2.85 DVPI
UT Southwestern Medical Center
Case Western Reserve
Employees
Steve Gillis, Ph.D.
(BARDA) – on updated slide deck
Columbia University
Dana Farber Cancer
Capital-efficiency
Alexandria Venture Investments
AI & Machine Learning
Apogen Biotechnologies
UT Southwestern
58.43% IRR
New York Office
Lodo Therapeutics
Penn State